Toxic shock syndrome is caused by bacterial production of exotoxins called superantigens. New therapeutic peptides reduce superantigen toxicity by interfering with the ability of superantigens to induce a cellular immune response, and also serve as potent adjuvants to increase the neutralizing antibody response (pages 414–421 ).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Todd, J.K., Kapral, F.A., Fishaut, M. & Welch, T.R. Toxic shock syndrome associated with phage group I staphylococci. Lancet 2, 1116–1118 ( 1978).
Stevens, D.L. et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321, 1–7 ( 1989).
Schlievert, P.M., Kotb, M.Y. & Stevens, D.L. in Effect of Microbes on the Immune System (eds. Cunningham, M.W. & Fujinami, R.S.) 25–39 (Lippincott Williams & Wilkins, Philadelphia, 2000).
Arad, G., Levey, R. Hillman, D. & Kaempfer, R. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation Nature Med. 6, 414– 421 (2000).
Marrack, P. & Kappler, J. The staphylococcal enterotoxins and their relatives. Science 248, 705– 711 (1990).
Li, H. et al. Three dimensional structure of the complex between a T cell receptor β chain and the superantigen staphylococcal enterotoxin B. Immunity 9, 807–816 ( 1998).
Jardetsky, T.S. et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368, 711–718 (1994).
Schlievert, P.M., Assimacopoulos, A.P. & Cleary, P.P. Severe invasive group A streptococcal disease: Clinical description and mechanisms of pathogenesis. J. Lab. Clin. Med. 127, 13–22 ( 1996).
Parsonnet, J., Gillis, Z.A., Richter, A.G. & Pier, G.B. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin-1. Infect. Immun. 55, 1070–1076 (1987).
Finkelman, F.D., Katona, I.M., Mosmann, T.R. & Coffman, R.L. IFN-regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140, 1022– 1027 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schlievert, P. Will therapeutic peptides be kryptonite for superantigens?. Nat Med 6, 378–379 (2000). https://doi.org/10.1038/74630
Issue Date:
DOI: https://doi.org/10.1038/74630